Benjamin M. Brucker, MD

• Assistant Professor, Urology
• New York University

This clinic did not segregate patients by age and perhaps allowed more opportunity for social interaction outside of the clinic gastritis juicing purchase bentyl 10 mg. Initial strains are usually unique and begin with strains from an environmental source gastritis diet ����� discount bentyl express. Although large bacterial colony counts exist in the airway (1 × 106/mL) without an acute illness and during periods of clinical stability gastritis uptodate bentyl 10 mg buy, there is still an exaggerated inflammatory response leading to airway destruction and disease progression gastritis symptoms in cats 10 mg bentyl purchase free shipping. The consequence of extended airway residence leads to changes in gene expression gastritis with hemorrhage symptoms generic bentyl 10 mg fast delivery, including formation of anaerobic biofilm such as alginate and progression of disease due to chronic infection. This is the result of AlgT, a gene that negatively regulates flagellar, pili, and quorum sensing (Rhl signal and Rhamnoloid). These sub-lineages found in different regions (sinus, central airway, and specific lobe), reflect the distribution and isolation in different compartments of the lung. Among the 36 patients eventually identified during the epidemic, only 10 are alive 8 years later and only 2 are clinically stable. The treatment of these drug-resistant strains is difficult and typically requires three to six concurrent antibacterials, including simultaneous use of more than one -lactam antibacterial. Fluoroquinolones; other -lactam antibiotics such as piperacillin-tazobactam, cefepime, and aztreonam; and imipenem have been used. Chronic infection is an independent risk factor for recurrent need for antibiotics. A longitudinal cohort study of 687 patients revealed a nearly threefold increase in mortality for those chronically infected with S. Time to next pulmonary exacerbation was significantly reduced: 64 days versus 107 days. The role of fungi in the respiratory tract, particularly Aspergillus fumigatus, is still being elucidated. In addition, the end points for studies comparing single versus combination therapies are likely also confounded. The mechanism of macrolide-associated improvement in lung disease is still uncertain, but azithromycin is thought to modulate inflammation and may in fact have some direct antimicrobial impact. Despite an increase in drug resistance, there was no significant impact of the emergence of drug resistance on lung function. Given susceptibility data in particular 883 patients, how should providers go about selecting antibiotics and what is the optimal length of therapy Clinical data supporting superiority of high doses are lacking, and therefore careful monitoring for toxicity and necessary dose adjustments should be made. In addition, patients with acute pulmonary infections should be tested for respiratory viruses, especially during influenza season. Prolonged or continuous infusion of -lactam antibiotics is being used with more frequency. Though the study did not achieve its primary outcome, it was likely due to lack of reliable outcome measures in this age group. Although there is still hope for gene therapy, high throughput screening of small molecules helped launch a new treatment paradigm. These therapies will not reverse damaged, bronchiectatic lungs with children, and those with mild disease are likely to experience the biggest impact on morbidity and mortality. As part of their pretransplant evaluation, all recent respiratory tract bacterial isolates are taken into consideration in preparing a tailored perioperative antimicrobial regimen. This antibacterial regimen is continued for 2 to 3 weeks postoperatively and is adjusted based on day-of-transplant bronchial cultures obtained from the recipient and donor. All patients receive inhaled colistin or tobramycin during their initial hospitalization to minimize the risk of anastomotic site infection. A majority of lung transplant centers adopted "universal" prolonged voriconazole prophylaxis when this antifungal was approved in 2002. Although this has probably led to lower incidence of fungal disease, most chronic toxicities of voriconazole use have been described in this population, especially phototoxicity, and periostitis probably from voriconazole-associated fluorosis. Analysis of fungal disease epidemiology in lung transplant patients at our center pointed to the fact that most fungal disease was related to perioperative contamination with Candida and Aspergillus and not a result of increased immunosuppression. Given these data, we implemented a "targeted" strategy in which all patients receive micafungin as part of their perioperative antimicrobial regimen beginning with induction of anesthesia and continued for 7 to 10 days. Patients also receive inhaled amphotericin twice daily during their initial hospitalization if they receive treatment for acute rejection. Once the explant pathology and day-of-transplant cultures are available, patients who had positive cultures for yeast or molds are treated with fluconazole or voriconazole depending on the fungal species identified and their susceptibilities, and this is continued for 3 to 6 months. With this strategy, approximately 10% of transplanted patients go home on voriconazole, and the incidence of fungal disease is comparable to centers that use "universal" strategies. This requires judicious interpretation of cultures obtained during surveillance bronchoscopies because cultures may represent oral or sinus contamination at the time of the procedures. Most early infections in lung transplant recipients are surgical site infections involving the pleural space, fractured ribs or soft tissue, and more rarely anastomoticsite infections. Persistence of Staphylococcus aureus strains among cystic fibrosis patients over extended periods of time. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. Activity of ceftazidime against Pseudomonas aeruginosa from bacteraemic and fibrocystic patients. Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study. The impact of newborn screening on cystic fibrosis testing in Victoria, Australia. The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era. Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis. Allergic bronchopulmonary aspergillosis in cystic fibrosis- state of the art: Cystic Fibrosis Foundation Conference. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis. Recommendations for management of liver and biliary tract disease in cystic fibrosis: Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group. Renal calcium handling in cystic fibrosis: lack of evidence for a primary renal defect. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data. Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis. Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis. Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis. Multiple antibioticresistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis. Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period. Antibiotic prophylaxis in infants and young children with cystic fibrosis: a randomized controlled trial. Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis. Presence of methicillin-resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function. Complex molecular epidemiology of methicillin-resistant Staphylococcus aureus isolates from children with cystic fibrosis in the era of epidemic community-associated methicillin-resistant S. Longitudinal survey of Staphylococcus aureus in cystic fibrosis patients using a multiple-locus variable-number of tandem-repeats analysis method. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Italian cystic fibrosis patients: a national overview. Panton-Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic. Does centralized treatment of cystic fibrosis increase the risk of Pseudomonas aeruginosa infection An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis center. Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients. Cystic fibrosis survival rates: the influence of allergy and Pseudomonas aeruginosa. Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary infection with Pseudomonas aeruginosa. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Approach to eradication of initial Pseudomonas aeruginosa infection in children with cystic fibrosis. Comparative efficacy and safety of four randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis. Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis. Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success Aminoglycosideresistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. Systems-level analysis of microbial community organization through combinatorial labeling and spectral imaging. Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients. Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Nontuberculous mycobacterial pulmonary infection in patients with cystic fibrosis: diagnosis and treatment. Respiratory viruses are associated with common respiratory pathogens in cystic fibrosis. The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation. Seasonal onset of initial colonization and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Effects of Aspergillus fumigatus colonization on lung function in cystic fibrosis. Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Intensive treatment of Pseudomonas chest infection in cystic fibrosis: a comparison of tobramycin and ticarcillin, and netilmicin and ticarcillin.

A randomized gastritis symptoms dizziness buy cheap bentyl 10 mg on line, placebo-controlled trial of antimicrobial treatment for children with clinically diagnosed acute sinusitis gastritis and diarrhea 10 mg bentyl buy. Commentary: antibiotic recommendations for acute otitis media and acute bacterial sinusitis in 2013-the conundrum gastritis diet ������� purchase bentyl amex. Endoscopic modified Lothrop procedure for the treatment of chronic frontal sinusitis: a systematic review diet by gastritis order bentyl canada. Healthcare expenditures for sinusitis in 1996: contributions of asthma gastritis diet mayo clinic bentyl 10 mg line, rhinitis, and other airway disorders. Acquired ciliary defects in nasal epithelium of children with acute viral upper respiratory infections. Nasal airflow, mucociliary clearance, and sinus functioning during viral colds: effects of allergic rhinitis and susceptibility to recurrent sinusitis. Do chronic changes in nasal airflow have any physiological or pathological effect on the nose and paranasal sinuses Microbiology of sinus puncture versus middle meatal aspiration in acute bacterial maxillary sinusitis. Comparison of maxillary sinus puncture with endoscopic middle meatal culture in pediatric rhinosinusitis. Microbiology of the middle meatus: a comparison between normal adults and children. Comparative evaluation of cefuroxime axetil and cefaclor for treatment of acute bacterial maxillary sinusitis. Comparative effectiveness and safety of cefdinir and amoxicillinclavulanate in treatment of acute community-acquired bacterial sinusitis. Frequency of recovery of pathogens causing acute maxillary sinusitis in adults before and after introduction of vaccination of children with the 7-valent pneumococcal vaccine. Staphylococcus aureus is a major pathogen in acute bacterial rhinosinusitis: a meta-analysis. The natural history of contemporary Staphylococcus aureus nasal colonization in community children. Invasive fungal sinusitis caused by Pseudallescheria boydii: case report and literature review. Lethal disseminated Fusarium infection with sinus involvement in the immunocompromised host: case report and review of the literature. Rhinocerebral mucormycosis complicated by internal carotid artery thrombosis in a pediatric patient with type 1 diabetes mellitus: a case report and review of the literature. Nosocomial sinusitis in patients in the medical intensive care unit: a prospective epidemiological study. Specific inflammatory cell types and disease severity as predictors of postsurgical outcomes in patients with chronic sinusitis. Microbiology of chronic maxillary sinusitis in adults: isolated aerobic and anaerobic bacteria and their susceptibility to twenty antibiotics. Bacteriology of chronic maxillary sinusitis and normal maxillary sinuses: using culture and multiplex polymerase chain reaction. Biofilms in chronic rhinosinusitis: systematic review and suggestions for future research. Illness in the Home: A Study of 25,000 Illnesses in a Group of Cleveland Families. Epidemiology of sinusitis in the primary care setting: results from the 1999-2000 respiratory surveillance program. Association between gastroesophageal reflux and sinusitis, otitis media, and laryngeal malignancy: a systematic review of the evidence. Use of symptoms, signs, and blood tests to diagnose acute sinus infections in primary care: comparison with computed tomography. Clinical practice guideline for diagnosis and management of acute bacterial sinusitis in children 1-18. Correlation of clinical sinusitis signs and symptoms to imaging findings in pediatric patients. Cross-sectional survey of paranasal sinus magnetic resonance imaging findings in schoolchildren. Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. Primary-care-based randomised placebocontrolled trial of antibiotic treatment in acute maxillary sinusitis. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. Effect of amoxicillinclavulanate in clinically diagnosed acute rhinosinusitis: a placebo-controlled, double-blind, randomized trial in general practice. Cefuroxime axetil versus placebo for children with acute respiratory infection and imaging evidence of sinusitis: a randomized, controlled trial. Treatment of acute rhinosinusitis diagnosed by clinical criteria or ultrasound in primary care. Randomised, double blind, placebo controlled trial of penicillin V in the treatment of acute maxillary sinusitis in adults in general practice. Azithromycin versus placebo in acute infectious rhinitis with clinical symptoms but without radiological signs of maxillary sinusitis. The end of antibiotic treatment in adults with acute sinusitis-like complaints in general practice Effectiveness of amoxicillinclavulanate potassium in the treatment of acute bacterial sinusitis in children: a double-blind, placebo-controlled trial. National trends in visit rates and antibiotic prescribing for adults with acute sinusitis. A double-blind, placebo-controlled trial of decongestantantihistamine for the treatment of sinusitis in children. The effect of saline solutions on nasal patency and mucociliary clearance in rhinosinusitis patients. The Pott puffy tumor revisited: neurosurgical implications of this unforgotten entity. Frequency of recovery of pathogens from the nasopharynx of children with acute maxillary sinusitis before and after the introduction of vaccination with the 7-valent pneumococcal vaccine. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data. Acute epiglottitis (supraglottitis) is an invasive cellulitis of the epiglottis and its adjacent supraglottic structures (aryepiglottic folds, vallecula) that has the potential for causing abrupt, complete airway obstruction. Although epiglottitis was reported in both children and adults in the first half of the 20th century, it became known as a classic pediatric infection by the 1970s. The virtual disappearance of classic pediatric epiglottitis is a direct consequence of the high protective efficacy of H. In general, no distinct pathogen is isolated; on occasion, other pathogens unrelated to H. In addition, injury from consumption of very hot beverages or illicit substances such as inhaled crack cocaine can result in burns of the epiglottis ("thermal epiglottitis"). It is possible that local physical trauma or irritation from preceding viral infection predisposes the epiglottis to bacterial infection. However, such an obstruction would not explain the success of bag-mask ventilation prior to intubation of these children. Laminar airflow in the small bronchioles is governed by the Poiseuille equation, which can be expressed as stating that resistance to airflow is inversely proportional to the fourth power of the luminal radius; however, pharyngeal airflow is turbulent, which is less efficient. Yet, in an older child or young adult with an 8-mm airway, the same 1 mm of circumferential edema reduces the cross-sectional area by only approximately 44% and increases the resistance only by about fivefold. Although most patients are in good health before onset of the disease, underlying conditions that compromise immunity may be a factor in some patients. Although the lateral neck radiograph thus can be very helpful in diagnosing epiglottitis, radiographs were not recommended to be performed in children with classic acute epiglottitis because of the risks in delaying securing the airway, as well as the requirement for sending an ill and potentially unstable child to the radiology department (portable neck radiographs were generally not sufficient to properly interpret the anatomic borders). The diagnosis of epiglottitis is definitively established by visualization of an edematous, cherry-red epiglottis by direct or indirect laryngoscopy or by nasal fiberoptic endoscopy. This emphasizes the need for a complete examination of the epiglottis in adults with severe sore throat or severe pharyngitis with odynophagia. In adults, examination in the sitting forward position, using a tongue depressor to gently depress the tongue, may reveal the epiglottis without the need for direct or indirect laryngoscopy. In subacute epiglottitis of the older child or adult, lateral neck radiographs should be obtained. Computed tomography of the neck is generally not required but may be useful for evaluation of epiglottic abscess. Although both illnesses can present as stridor, a toxic appearance is more common in epiglottitis. In a comparative analysis of 203 ill children with either epiglottitis or croup, the presence of drooling oral secretions was 79% sensitive and 94% specific for the diagnosis of epiglottitis; the absence of coughing was similarly predictive (98% sensitivity and 100% specificity). However, differentiation of epiglottitis from croup is sometimes difficult unless the epiglottis is visualized. Retropharyngeal abscess, peritonsillar abscess, and uvulitis (invasive bacterial infections generally caused by S. Bacterial tracheitis may be confused with epiglottitis, especially in a patient who has already had antibiotic therapy and may have staphylococcal overgrowth in the trachea; the appearance on laryngoscopy or intubation should clarify the diagnosis. Diphtheria can be differentiated from epiglottitis by the presence of a pseudomembrane in the respiratory tract and the presence of typical organisms on direct smear and culture of the membrane. Case series and widespread experiential data report that 70% to 100% of children with classic pediatric epiglottitis have undergone intubation for airway management and generally a small number (<5%) have emergent tracheotomy or cricothyroidotomy. In contrast, it appears reasonably safe for the adult with epiglottitis to be managed without intubation but with careful observation in an intensive care unit with the capability to secure an artificial airway immediately on impending airway compromise (increasing stridor or dyspnea). Children who are suspected of having acute epiglottitis should be handled as a medical emergency because of the potential for rapid deterioration to complete respiratory obstruction. Painful or anxiety-provoking procedures (including phlebotomy and lateral neck radiography) should be minimized until the airway is secured or the diagnosis has been excluded. Patients being transported between and even within medical facilities must be accompanied by personnel capable of securing the airway in case obstruction occurs. At the same time, bag-mask ventilation should not be forgotten if intubation or cricothyroidotomy is not possible, because the obstruction is usually not absolute. Appropriate management of the child with classic pediatric epiglottitis requires the immediate insertion of an endotracheal tube; this procedure is both therapeutic and diagnostic, because visualization of After the establishment of an airway, cultures should be obtained from blood and, if possible. Antibiotic therapy is directed at the most likely causative bacterial pathogens (H. This is best accomplished by the use of a third-generation cephalosporin such as ceftriaxone or cefotaxime or a -lactamase inhibitor combination drug such as ampicillin-sulbactam; for immunocompromised individuals, piperacillin-tazobactam would offer increased coverage for gramnegative organisms while still including the more typical causes. Vancomycin should be added if high-grade penicillin-resistant pneumococci are prevalent in the area or if methicillin-resistant staphylococcal bacterial tracheitis is a diagnostic possibility. For individuals allergic to -lactams, a combination of a fluoroquinolone (levofloxacin or moxifloxacin) and clindamycin is suggested. Trimethoprim-sulfamethoxazole and clindamycin in combination might also be considered for the -lactam­allergic patient, depending on the local prevalence of resistance among pneumococci. Pediatric patients with acute epiglottitis usually improve approximately 48 hours after the initiation of appropriate antibiotic therapy. The role of nebulized epinephrine, corticosteroids, or other adjuncts to therapy is unknown; evidence of benefits from such interventions is lacking. However, children who are treated with ampicillin-sulbactam or other agents will require "terminal prophylaxis" with rifampin at the end of their primary treatment, to prevent reintroduction of the organism into the household. Contacts of older children and adults with epiglottitis do not require chemoprophylaxis at all, except in the rare case of documented meningococcal or H. Progress toward elimination of Haemophilus influenzae type b disease among infants and children-United States, 1987-1993. Epiglottitis in Sweden before and after introduction of vaccination against Haemophilus influenzae type b. Changes in the epidemiology of epiglottitis following introduction of Haemophilus influenzae type b (Hib) conjugate vaccines in England: a comparison of two data sources. Epiglottitis: incidence of extraepiglottic infection: report of 72 cases and review of the literature. Supraglottitis in the era following widespread immunization against Haemophilus influenzae type B: evolving principles in diagnosis and management. Acute epiglottitis: epidemiology and Streptococcus pneumoniae serotype distribution in adults. Disappearance of epiglottitis during large-scale vaccination with Haemophilus influenzae type B conjugate vaccine among children in Finland. Epiglottitis in adults and children in Olmsted County, Minnesota, 1976 through 1990. Epiglottitis and Haemophilus influenzae immunization: the Pittsburgh experience-a five-year review. Acute epiglottitis in adults: an eight-year experience in the state of Rhode Island. Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children-United States, 1998-2000. Changing patterns in pediatric supraglottitis: a multi-institutional review, 1980 to 1992. Emergency imaging assessment of acute, nontraumatic conditions of the head and neck. Chapter 64 Epiglottitis 789 65 Definition Infections of the Oral Cavity, Neck, and Head Anthony W. Odontogenic orofacial infections include dental caries, pulpitis, peri apical abscess, gingivitis, periodontal disease, and infections in the deep fascial spaces. Complications such as intracranial, retropharyn geal, or pleuropulmonary extension and hematogenous dissemination to heart valves, prosthetic devices, and other metastatic foci, although rare, clearly indicate the potentially serious nature of these infections. Nonodontogenic infections of the oral cavity include ulcerative muco sitis, which complicates radiation and chemotherapy; noma (gangre nous stomatitis); and infection of the major salivary glands.

In the appropriate clinical setting gastritis anxiety bentyl 10 mg buy with mastercard, sudden development of dermal nodules may suggest candidal sepsis (see later discussion) gastritis diet quality bentyl 10 mg purchase on-line, but other fungal diseases including blastomycosis gastritis diet garlic 10 mg bentyl buy otc, histoplasmosis xenadrine gastritis bentyl 10 mg order visa, coccidioidomycosis gastritis diet ������� cheap bentyl 10 mg buy on-line, and sporotrichosis may produce skin nodules. Bacteria such as Nocardia and nontuberculous mycobacteria114-116 (especially Mycobacterium marinum)117 may also cause nodular lesions (which typically later ulcerate). Lesions consistent with ecthyma gangrenosum, typified by the presence of deep, "punchedout" ulcerations with overlying black eschar and peripheral erythema, suggest Pseudomonas sepsis. A skin biopsy specimen with appropriate stains and cultures defines the diagnosis. Subcutaneous nodules pose a real diagnostic challenge, because they may reflect the presence of a variety of underlying disorders, including hypersensitivity reactions to systemic infection. The lesions of erythema nodosum are characterized by tender, erythematous nodules that range in diameter from less than a centimeter to several centimeters. These lesions often develop in crops and usually heal in days to a few weeks without scarring. These lesions tend to suppurate, distinguishing them morphologically from erythema nodosum and most other types of panniculitis. Furthermore, erythema induratum can usually be easily differentiated from erythema nodosum on histologic examination of a wedge biopsy specimen: inflammation can be seen within subcutaneous fat lobules in the former, rather than within septal connective 738 tissue as classically seen in erythema nodosum. Acid-fast bacilli are rarely visible within the lesions of erythema induratum, because this condition typically represents reactivation of long-standing infection with, or hypersensitivity to , the tuberculosis bacilli that are present at distant sites. The most common infectious agents include gram-negative organisms, especially Neisseria meningitidis, and rickettsiae. Asplenic patients are at an increased risk for overwhelming sepsis (lifetime risk of approximately 5%), which may be accompanied by symmetrical peripheral gangrene. Streptococcus pneumoniae is responsible for 50% to 90% of infections in the asplenic patients and has a mortality rate of approximately 50%. Additional occasional pathogens include Staphylococcus aureus, group B streptococci, Enterococcus, Escherichia coli and other Enterobacteriaceae, Salmonella, Campylobacter, Bacteroides, Bordetella holmesii, Pseudomonas, and Babesia spp. Although children with coxsackievirus and echovirus infections are usually nontoxic in appearance, some may appear very ill. In these patients, differential diagnosis from acute meningococcemia is difficult. However, in a series of children presenting with fever and petechiae, only 8% had meningococcal infections and 4% had bacterial sepsis secondary to other disorders. An eschar (tache noire) characteristically develops at the site of inoculation in the following rickettsial infections (infecting species): African tick bite fever (R. New rickettsioses continue to be recognized worldwide that are characterized by generalized skin lesions, often with tache noire lesions such as Japanese or Oriental spotted fever (R. The most important causes of noninfectious petechiae are thrombocytopenia, large and small vessel necrotizing vasculitis (usually presenting as palpable purpura), and the pigmented purpuric eruptions (which usually represent capillaritis). Desquamation may occur late in all of these syndromes, and its absence early in the clinical course should not be considered a reason for excluding any disease process. Most vesiculobullous eruptions are immunologic in origin; few are associated with infectious systemic infections. Infectious diseases to be considered include varicella, disseminated herpes simplex, eczema herpeticum (herpes simplex superinfection of atopic eczema), and infections due to echoviruses and coxsackieviruses (including coxsackievirus A16, a cause of hand-foot-and-mouth disease). In addition, other poxvirus infections such as monkeypox, smallpox, and generalized vaccinia need to be considered (see later). Bullous skin lesions with sepsis are suggestive of the following infections: group A streptococcal erysipelas with necrotizing fasciitis (gangrenous erysipelas), ecthyma gangrenosum (due to Pseudomonas aeruginosa or Aeromonas spp. Rarely, in immunocompromised patients the initial manifestation of gram-negative sepsis may be the appearance of a solitary hemorrhagic blister. In critically ill patients, these lesions are often associated with symmetrical peripheral gangrene (purpura fulminans), Enanthems In attempting to classify the enanthem, it is essential that a thorough search of the mucous membranes (including the mouth, conjunctiva, and occasionally also the vagina, rectum, and glans penis) be made for the presence of enanthems. Koplik spots, diagnostic of 739 rubeola, are tiny, white or blue-gray specks superimposed on an erythematous base, located on the buccal mucosa, most prominently on that adjacent to the molars. Petechiae of the palate are common in scarlet fever and some vasculitides and with thrombocytopenia. In infectious mononucleosis, petechiae of both the hard palate and soft palate are common. Oral ulcers occur in a variety of noninfectious immunologic diseases and also with coxsackievirus A16 infection. Various systemic bacterial infections may spread to the skin, generally producing discrete lesions from which the organisms can be isolated or recognized on biopsy with special stains. Symmetrical peripheral gangrene is preceded by bleeding into the skin, ecchymosis, purpura, and acrocyanosis (a grayish cyanosis that does not blanch on pressure and occurs on the lips, legs, nose, ear lobes, and genitalia). Subsequently, the ecchymotic lesions become confluent, blister, undergo necrosis and ulceration, and develop overlying eschars. Histologic examination reveals a Schwartzman-like reaction in the skin characterized by diffuse and extensive hemorrhages, perivascular cuffing, and intravascular thrombosis. As noted earlier, purpura fulminans may follow a benign infection, especially in children. Common preceding illnesses include scarlet fever, streptococcal pharyngitis, staphylococcal bacteremia, varicella, and measles. The classic syndrome is more frequent in women between the ages of 30 and 50 years, is often preceded by symptoms of an upper respiratory tract infection, and may be associated with inflammatory bowel disease and pregnancy. The skin demonstrates one or more tender, red, edematous, urticarial plaques or large papules. Often the border of each plaque is studded with papules (or, infrequently, with vesicles or pustules), giving an irregularly contoured, mammillated appearance reminiscent of that of the areolae of the breast. Occasionally, these plaques become dusky in color and frankly hemorrhagic, suggesting instead erythema multiforme or leukocytoclastic vasculitis. Some lesions may also become bullous, suggesting bullous erythema multiforme or fixed drug eruption. Second-line systemic agents include colchicine, dapsone, potassium iodide, tumor necrosis factor- antagonists, and cyclosporine. The following discussion reviews the various skin manifestations of these pathologic processes. Sepsis is a clinical syndrome that complicates severe infection and is characterized by inflammation, including vasodilation, increased microvascular permeability, and end-organ dysfunction. Hemorrhagic skin lesions have been present in 28% to 77% of patients with invasive meningococcal disease. The petechiae are irregular and small and are often accompanied by palpable purpuric lesions, some of which may have pale centers. Coalescing lesions, often macular, may have a characteristic gun-metal gray color centrally, consistent with epidermal necrosis. Lesions most commonly occur on the extremities and trunk but may also be found on the head, palms and soles, and mucous membranes. Histologic examination reveals diffuse endothelial damage, fibrin thrombi, necrosis of the vessel walls, and perivascular hemorrhage in the involved skin. Gram staining of aspirates of the involved areas frequently reveals the presence of organisms. The classic clinical constellation of symptoms includes intermittent or sustained fevers; recurring maculopapular, nodular, pustular, or petechial eruptions; and migratory arthritis or arthralgias with little systemic toxicity. Petechiae of variable size may be seen, with superimposed vesicles or pustules centrally. Small, irregularly round, subcutaneous hemorrhages with a bluish gray center containing pus cells are a distinctive lesion of this syndrome. Ecchymotic areas or hemorrhagic, tender nodules that are located deep in the dermis may also occur. Lesions associated with chronic meningococcemia tend to appear in showers in association with the onset of fever. In contrast to the lesions associated with fulminant meningococcemia, those of chronic meningococcemia rarely include organisms demonstrable on Gram-stained smear or biopsy specimen. In addition, purpura fulminans is not a typical finding in chronic meningococcemia. A number of diseases with periodic fever, skin lesions, and joint involvement may resemble chronic meningococcemia, including subacute bacterial endocarditis, acute rheumatic fever, Henoch-Schönlein purpura, ratbite fever, erythema multiforme, and chronic gonococcemia. The eruption typically appears during the first day of symptoms and may recur with each bout of fever. Papules, bullae, pustules, and hemorrhagic lesions all may be present simultaneously. The distal portions of the extremities are most commonly involved (at times associated with tenosynovitis), with sparing of the scalp, face, trunk, and oral mucous membranes. Gramstained smears of material from skin lesions infrequently contain organisms, although most smears are positive for gonococci when examined by immunofluorescence techniques. They may also cause infection in normal hosts, especially when the skin has been moistened. First, vesicles and bullae may occur singly or in clusters and frequently are spread in random fashion over the skin. Second, gangrenous cellulitis may occur as a sharply demarcated, superficial, painless, necrotic lesion. It may also begin abruptly as an acute infection with local pain, swelling, and erythema and involve deep tissue and fascia. Third, macular or papular nodular lesions are located predominantly over the trunk; the lesions are small, oval, and painless. Finally, ecthyma gangrenosum is a lesion characteristic but not pathognomonic of P. Later, the lesion sloughs to form a deep gangrenous ulcer with a gray-black eschar and a surrounding erythematous halo. Lesions may be discrete or multiple and are usually found in the groin, axillary, or perianal areas but may occur anywhere on the body. Bacteria are readily visible in biopsy samples and can be demonstrated in Gram-stained material scraped from the base of the lesion. Characteristically, the nodules are erythematous and warm, may be either fluctuant or nonfluctuant, and may be tender. Despite prolonged antibiotic therapy, these lesions may contain viable bacteria weeks after the blood has been cleared of infection. The absence of fluctuance may be due to either the lack of pus in neutropenic patients or the deep location of the abscess, or both. Although successful treatment may require incision and drainage,176,177 prolonged antibiotic therapy without drainage may result in a cure. The prevalence of embolic and hypersensitivity lesions in skin and mucous membranes (50%) in heroin-associated infective endocarditis is similar to that described in patients with non­heroinassociated infective endocarditis. The petechiae may be observed on the skin, especially on the heels, shoulders, and legs. These lesions are tender, indurated, erythematous nodules, with a pale center that is 1. The lesions usually resolve without necrosis or suppuration 1 to 3 days after antibiotic therapy is initiated. Although they may be seen in subacute bacterial endocarditis, they are more common in acute endocarditis, especially that due to S. Histologically, they show microabscesses with neutrophil infiltration of capillaries. The toxins act as superantigens binding directly to the V chain of the T-cell receptor and to the major histocompatibility complex molecule, which triggers clonal expansion of the T cells and an unregulated outpouring of proinflammatory cytokines. The most common symptoms include a temperature greater than 40° C (104° F), hypotension, and diffuse erythroderma with desquamation 1 to 2 weeks after the onset of illness. Additional early features include conjunctival, oropharyngeal, and vaginal hyperemia; vomiting and diarrhea; and myalgias. Most patients have abnormalities in three or more organ systems: (1) muscular: rhabdomyolysis; (2) central nervous system: toxic encephalopathy; (3) renal: azotemia; (4) liver: abnormal aminotransferase levels; and (5) hematologic: thrombocytopenia. Such skin lesions have been reported in 10% to 64% of patients with staphylococcal septicemia. Gram-stained smears of the material in these lesions usually demonstrate gram-positive cocci. Skin lesions may occur as tender red abscesses that are commonly misinterpreted as "spider bites" by the patient. Other soft tissue infections described include chronic external otitis, paronychia, cellulitis, necrotizing fasciitis, and necrotizing myositis. Although mortality in appropriately treated children is less than 4%, in adults it can reach almost 60%. Bullous impetigo, a disorder usually confined to children that results from toxin-producing strains of S. The bullae rapidly rupture, leaving raw, denuded erosions that reepithelialize in 5 to 7 days. Rheumatic fever affects up to 3% of people with untreated group A hemolytic streptococcal infections of the nasopharynx. Cutaneous manifestations include erythema marginatum (occurring in 10% to 20% of cases), subcutaneous nodules (in up to 30%), and erythema papulatum (rare). Scarlet fever is a diffuse erythematous eruption that results from the production of pyrogenic exotoxin (erythrogenic toxin) produced by S. There appear to be three distinct exotoxins (types A, B, and C) produced by approximately 90% of group A strains. The rash of scarlet fever requires both the presence of pyrogenic exotoxin and the existence of delayed-type skin reactivity to streptococcal products. The pharynx is usually beefy red with edema involving the tonsillar area extending anteriorly to the soft palate and uvula. The rash of scarlet fever usually starts on the head and neck and then rapidly expands to cover the trunk and finally the extremities. The rash is a diffuse erythema, blanching on pressure, with numerous small (1 to 2 mm) papular elevations, giving a "sandpaper" quality to the skin.

Order bentyl with visa. What not to eat when you have gastritis ? | BEST Health FAQs.

Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir gastritis y limon order bentyl 10 mg with visa. Clinical responses to cidofovir applied topically in women with high grade vulval intraepithelial neoplasia gastritis diet ��� buy generic bentyl canada. Characterization of wild-type and cidofovir-resistant strains of camelpox gastritis diet ���� discount bentyl 10 mg overnight delivery, cowpox gastritis diet ���������� discount bentyl 10 mg buy, monkeypox gastritis definicion order 10 mg bentyl mastercard, and vaccinia viruses. Clinical pharmacokinetics of cidofovir in human immunodeficiency virusinfected patients. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis. Case of progressive dysplasia concomitant with intralesional cidofovir administration for recurrent respiratory papillomatosis. Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child. Cytomegalovirus encephalitis/retinitis in allogeneic hematopoietic stem cell transplant recipient successfully treated with combination of cidofovir and foscarnet. Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients. Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Successful clearance of cutaneous acyclovir-resistant, foscarnet-refractory herpes virus lesions with topical cidofovir in an allogeneic hematopoietic stem cell transplant patient. Oral topical cidofovir: novel route of drug delivery in a severely immunosuppressed patient with refractory multidrug-resistant herpes simplex virus infection. Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis. Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study. Treatment of locally recurrent Epstein-Barr virus-associated nasopharyngeal carcinoma using the anti-viral agent cidofovir. The management of oral human papillomavirus with topical cidofovir: a case report. Refractory human papillomavirus-associated oral warts treated topically with 1-3% cidofovir solutions in human immunodeficiency virus type 1-infected patients. Disseminated molluscum contagiosum during topical treatment of atopic dermatitis with tacrolimus: efficacy of cidofovir. The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir. The anti-herpes simplex virus activity of n-docosanol includes inhibition of the viral entry process. Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream, acyclovir cream, and n-docosanol cream against experimental cutaneous herpes simplex virus type 1 infection. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: a multicenter, randomized, placebo-controlled trial. In vitro activities of penciclovir and acyclovir against herpes simplex virus types 1 and 2. Penciclovir: a review of its spectrum of activity, selectivity and cross-resistance pattern. In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir. Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells. Famciclovir and valaciclovir differ in the prevention of herpes simplex virus type 1 latency in mice: a quantitative study. Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream, acyclovir cream and n-docosanol cream against experimental cutaneous herpes simplex virus type 1 infection. Effects of penciclovir and famciclovir in a murine model of encephalitis induced by intranasal inoculation of herpes simplex virus type 1. Penciclovir and pathogenesis phenotypes of drug-resistant herpes simplex virus mutants. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women: a multicenter, double-blind, placebocontrolled trial. Famciclovir and penciclovir: the mode of action of famciclovir including its conversion to penciclovir. Safety and pharmacokinetics of a single 1500 mg dose of famciclovir in adolescents with recurrent herpes labialis. Single-dose pharmacokinetics of famciclovir in infants and population pharmacokinetic analysis in infants and children. Pharmacokinetics and safety of famciclovir in children with herpes simplex or varicella-zoster virus infection. Drug interaction studies and safety of famciclovir in healthy volunteers: a review. Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial [erratum in Clin Infect Dis. Effect of long-term famciclovir treatment on sperm parameters in patients with recurrent genital herpes. Single-day, patientinitiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind comparative trial. Clinic-initiated, twicedaily oral famciclovir for treatment of recurrent genital herpes: a randomized, double-blind, controlled trial. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Famciclovir suppression of asymptomatic and symptomatic recurrent anogenital herpes simplex virus shedding in women: a randomized, double-blind, doubledummy, placebo-controlled, parallel-group, single-center trial. Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trials. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding. Intravenous penciclovir for treatment of herpes simplex infections in immunocompromised patients: results of a multicenter, acyclovir-controlled trial. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia-a randomized, double-blind, placebo-controlled trial. Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients. Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompromised adults: a randomized, multicenter, double-blind clinical trial. Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster. A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients. Comparison of the efficacy of lamivudine and famciclovir in Asian patients with chronic hepatitis B: results of 24 weeks of therapy. Combination therapy with lamivudine and famciclovir for chronic hepatitis B infection. Selection of multiresistant hepatitis B virus during sequential nucleosideanalogue therapy. Famciclovir treatment of hepatitis B infection following liver transplantation: a long-term, multi-centre study. The effect of famciclovir on delayed facial paralysis after acoustic tumor resection. Foscarnet: a reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections. Zidovudine resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet. Cytomegalovirus/encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipients treated successfully with combination of cidofovir and foscarnet. Intravenous foscarnet in the management of acyclovir-resistant herpes simplex virus type 2 in acute retinal necrosis in children. Intravitreal foscarnet for the treatment of acyclovir-resistant acute retinal necrosis caused by varicella zoster virus. Severe encephalomyelitis in an immunocompetent adult with chromosomally integrated human herpesvirus 6 and clinical response to treatment with foscarnet plus ganciclovir. Ganciclovir-resistant human herpesvirus-6 encephalitis in a liver transplant patient: a case report. Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet. Cytokine responses in a severe case of glandular fever treated successfully with foscarnet combined with prednisolone and intravenous immunoglobulin. Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Rat adenocarcinoma cell line infected with an adenovirus carrying a novel herpessimplex virus-thymidine kinase suicide gene construct dies by apoptosis upon treatment with ganciclovir. Effects of food on absorption of ganciclovir after oral administration in healthy volunteers. Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients. Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation. Pharmacokinetics of ganciclovir after oral valganciclovir versus intravenous ganciclovir in allogeneic stem cell transplant patients with graft-versus-host disease of the gastrointestinal tract. Establishing pharmacokinetic bioequivalence of valganciclovir oral solution versus the tablet formulation. Ganciclovir pharmacokinetics and suggested dosing in continuous venovenous haemodiafiltration. Disposition of valganciclovir during continuous renal replacement therapy in two lung transplant recipients. Ganciclovir antagonizes the anti-human immunodeficiency virus type 1 activity of zidovudine and didanosine in vitro. Neutropenia related to valacyclovir and valganciclovir in 2 renal transplant patients and treatment with granulocyte colony stimulating factor: a case report. Neurotoxicity related to valganciclovir in a child with impaired function: usefulness of therapeutic drug monitoring. Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder. Randomized trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. Poster presented on behalf of the Valganciclovir Solid Organ Transplant Study Group. Presented at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy Late-Breaker Program/Abstracts and Exhibits Addendum. Impact of valganciclovir on Epstein-Barr virus polymerase chain reaction in pediatric liver transplantation: preliminary report. Successful ganciclovir therapy in a patient with human herpesvirus-6 encephalitis after unrelated cord blood transplantation: usefulness of longitudinal measurements of viral load in cerebrospinal fluid. Human herpesvirus 6 meningoradiculitis treatment with intravenous immunoglobulin and valganciclovir. Post-liver transplantation multicentric Castleman disease treated with valganciclovir and weaning of immunosuppression. High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy. Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma. Successful treatment of Epstein-Barr virus-related encephalomyelitis with steroid and ganciclovir. Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study. Synergistic combination effect of cidofovir and idoxuridine on vaccinia virus replication. Emergence of cross-resistant herpes simplex virus following topical drug therapy in rabbit keratitis. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Topical liposomal gel of idoxuridine for the treatment of herpes simplex: pharmaceutical and clinical implications. Early application of topical 15% idoxuridine in dimethyl sulfoxide shortens the course of herpes simplex labialis: a multicenter placebo-controlled trial. Effect of adenine arabinoside on severe herpesvirus hominis infections in man: preliminary report. In vitro activities of benzimidazole d- and l-ribonucleosides against herpesviruses. Pharmacokinetics of maribavir, a novel oral anticytomegalovirus agent, in subjects with varying degrees of renal impairment. These nucleoside analogues require metabolic activation within the cell by phosphorylation (to a nucleoside analogue triphosphate or nucleotide analogue diphosphate). In chronic hepatitis B, oral antiviral agents can suppress viral replication by up to approximately 4 to 7 log10, which, in turn, translates to immediate biochemical (return to normal of aminotransferase activity), histologic (improvement in grade of necroinflammatory activity and grade of fibrosis), and serologic (seroconversion from hepatitis B 563 563.

References

• Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian acute Stroke Study Investigators. Lancet 1998;352:1245-51.
• Salman B, Brat G, Yoon YS, et al. The diagnosis and surgical treatment of pancreatoblastoma in adults: a case series and review of the literature. J Gastrointest Surg 2013;17(12):2153-2161.
• Seifer DB, Gutmann JN, Doyle MB, et al. Persistent ectopic pregnancy following laparoscopic linear salpingostomy. Obstet Gynecol 1990; 76:1121-1125.
• Caparrelli DJ, Freischlag J. A unified approach to axillosubclavian venous thrombosis in a single hospital admission. Semin Vase Surg. 2005;18:153-157.
• Johnson BE, Fischer T, Fischer B, et al. Phase II study of imatinib in patients with small cell lung cancer. Clin Cancer Res 2003;9(16 Pt 1):5880-5887.
• Keith A: On the origin and nature of hernia. Br J Surg 11:455, 1924-5.